Kevin Esvelt, Biosecurity, and the Risk of Engineered Pandemics

Advances in biotechnology and artificial intelligence are unlocking extraordinary possibilities in medicine, agriculture, and environmental conservation — but they also create unprecedented risks. Few people embody that tension more clearly than Kevin Esvelt, an MIT synthetic biologist known both for pioneering powerful genetic tools and for warning about their misuse.

This article explores how new biological capabilities could enable two kinds of catastrophic pandemics — stealth and wildfire — and outlines practical systems the world can build to reduce those dangers before it is too late.

From Engineering Evolution to Managing Global Risk

Kevin Esvelt directs the Sculpting Evolution group at the MIT Media Lab, where his team develops new ways to study and influence evolution safely. He helped pioneer the use of CRISPR gene editing and was the first to recognize that CRISPR could be turned into a “gene drive” system capable of spreading genetic traits through wild populations.

That realization forced an ethical pivot. If one lab could in principle alter an entire species in the wild, the implications for ecosystems — and global security — were profound. Esvelt became a leading voice for:

• Open discussion of risky technologies before they are deployed
• Community engagement in ecological engineering projects
• New safeguards against accidental or deliberate misuse of biotechnology

In recent years, much of his work has shifted from ecological applications of gene drive to pandemic prevention, particularly in a world where AI tools make it easier for more people to design biological agents.

Stealth vs Wildfire Pandemics: Two Routes to Disaster

COVID-19 revealed how disruptive a highly transmissible respiratory virus can be, even with a relatively modest infection fatality rate. Yet researchers studying global catastrophic biological risks are concerned about threats that could be far worse.

Esvelt and other experts often distinguish between two extreme scenarios:

What makes a “stealth” pandemic?

A stealth pandemic is shaped less like a sudden explosion and more like slow, creeping fog. It may begin with:

• Mild or non-specific symptoms that resemble common illnesses
• A long infectious period, allowing silent spread before detection
• Biology optimized to evade existing surveillance systems

Because public health monitoring often relies on specific pathogen tests, hospitalizations, or mortality trends, an engineered agent that moves gradually, especially in younger or healthier populations, could circulate widely before anyone realizes a new disease exists.

The risk is amplified by the global volume of respiratory infections each year. Seasonal respiratory viruses already cause millions of severe cases and hundreds of thousands of deaths worldwide, making small early changes hard to interpret.[10]

What makes a “wildfire” pandemic?

A wildfire pandemic is what most people imagine when they think of a nightmare pathogen:

• Extremely high basic reproduction number (R0)
• Severe disease or high lethality in a large fraction of infected people
• Short doubling time, so case numbers explode within days

Historically, naturally arising pathogens have encountered trade-offs between virulence and transmission. For example, diseases that incapacitate or kill hosts very quickly may limit their own spread.[11] Artificial design, however, might seek to circumvent such trade-offs, at least temporarily, by carefully tuning incubation periods, transmission routes, and tissue tropism.

In that world, traditional control tools — border closures, quarantine, and even mass vaccination — might not be fast enough to prevent catastrophic global impact.

Why Emerging Technologies Change the Risk Landscape

The danger of these extreme scenarios does not arise in a vacuum. It is closely tied to two accelerating trends:

• The rapid maturation of synthetic biology and genome engineering
• The spread of powerful AI models that can assist scientific design tasks

Biology is becoming programmable

Genome-scale engineering methods now allow researchers to modify organisms at many sites across their DNA, automate mutation and selection cycles, and design completely new genetic sequences. Tools such as CRISPR-based editing and directed evolution platforms have revolutionized what can be done in small labs.

These technologies are overwhelmingly used for beneficial aims:

• Developing vaccines and antiviral drugs
• Engineering microorganisms for sustainable manufacturing
• Studying basic cellular processes and evolution

At the same time, the barrier to entry is falling. DNA synthesis services, low-cost equipment, and extensive open scientific literature make it easier for a growing number of people to manipulate biological systems — including pathogens.

AI systems could lower expertise barriers

Artificial intelligence models trained on biological literature, genome data, and experimental results can already assist with tasks like protein design and gene sequence optimization. As these models become more capable and accessible, they might help:

• Propose genetic modifications that increase stability or transmissibility
• Simulate viral proteins that bind more effectively to human receptors
• Generate experimental protocols tailored to specific labs

Expert groups, including those advising national governments, have warned that AI-enabled biological design tools could be misused by individuals who lack deep wet-lab experience but possess malicious intent. This intersection of AI and synthetic biology is a central reason why Esvelt argues that the world should invest heavily in new defensive infrastructure now.

From Breakthroughs to Safeguards: Esvelt’s Biosecurity Agenda

Instead of focusing only on restricting research, Esvelt advocates building systemic defenses that make catastrophic misuse of biology much harder. Two of the most important proposals are:

• Universal DNA synthesis screening to block access to dangerous sequences
• A global early-warning network for detecting any pandemic-capable agent

Securing the DNA supply chain

Modern biology relies heavily on commercial DNA synthesis companies, which manufacture custom genetic sequences to order. This creates a natural control point: by screening incoming sequence requests and customers, providers can help prevent dangerous constructs from being produced.

Esvelt has helped found initiatives such as SecureDNA, which aims to create a technical and governance framework so that all DNA synthesis worldwide is screened for sequences associated with known or plausible pandemic agents.

Key principles include:

• Comprehensive coverage: All commercial DNA orders, regardless of size, should undergo automated screening.
• Privacy-preserving design: Cryptographic techniques can allow sequence checks without fully exposing customer data to third parties.
• Global adoption: To avoid “shopping around” for unregulated providers, major companies and governments would need to align on standards.

The value of such screening is two-fold:

• It directly reduces the chance that known high-risk agents or components are synthesized.
• It creates a foundation that can be updated as researchers discover new risk factors.

Building a global nucleic acid observatory

Even with strong controls on DNA synthesis, nature will continue to generate new pathogens. To catch both natural and artificial threats early, Esvelt and colleagues propose a global “nucleic acid observatory” — an early warning system that continuously monitors the biological signals in our environment.

The basic idea builds on tools proven during COVID-19:

• Wastewater surveillance can detect viral RNA from infected individuals before clinical testing catches up.[12]
• High-throughput sequencing technologies can read vast numbers of genetic fragments from environmental samples.
• Statistical and machine learning methods can flag unusual patterns in that data.

A full-scale observatory would extend these ideas globally, by:

• Collecting wastewater and air samples from many cities and transportation hubs
• Sequencing genetic material to identify any organism whose abundance is rapidly increasing
• Triggering alerts for further investigation when anomalous signatures are detected

Crucially, such a system would not need to know in advance which pathogen to look for. It would focus on detecting unusual exponential growth of any biological agent in human-associated environments, buying time for public health responses.

Delay, Detect, Defend: A Strategy for Surviving Engineered Pandemics

Many of Esvelt’s proposals can be organized under a simple three-part strategy, echoed in other biosecurity work: delay, detect, and defend.

1. Delay: Make dangerous misuse slower and harder

The “delay” component focuses on raising barriers without stopping legitimate science.

• DNA synthesis screening forces would-be attackers to either circumvent global systems or attempt more technically demanding paths.
• Responsible publication norms can limit detailed step-by-step methods for constructing highly transmissible pathogens, while still sharing high-level scientific insights.
• Laboratory biosafety standards and training reduce the risk that risky experiments inadvertently leak into the world.[13]

2. Detect: Catch outbreaks at the earliest possible moment

Early detection offers the largest multiplier on all other interventions.

• Environmental surveillance through a nucleic acid observatory provides non-clinical signals of new biological agents.[12]
• Clinical sequencing of unusual cases helps identify novel pathogens and track evolution during outbreaks.[12]
• Integrated data systems allow real-time analysis of signals from hospitals, labs, and environmental monitoring.

Experience from COVID-19 showed that wastewater signals of SARS-CoV-2 often rose days to weeks before spikes in diagnosed cases, demonstrating how valuable such lead time can be for public health decisions.[12]

3. Defend: Respond quickly and robustly to new threats

Detection only matters if societies can act on the information.

• Platform vaccines such as mRNA can be rapidly reprogrammed once a pathogen’s genetic sequence is known, enabling faster vaccine development and deployment.[14]
• Broad-spectrum antivirals and monoclonal antibodies offer early treatment options while vaccines are in development.[14]
• Non-pharmaceutical interventions — high-quality masks, improved ventilation, and isolation of cases — remain essential, especially for fast-moving threats.[11]

Esvelt and collaborators also highlight emerging physical countermeasures, such as far-UVC lighting systems that can inactivate airborne pathogens in occupied indoor spaces while remaining safe for humans at appropriate doses. Pilot studies suggest that such systems could dramatically reduce transmission of respiratory viruses in high-risk environments, though further research and standards development are ongoing.

Ethics, Openness, and Public Trust

Technical measures alone cannot solve biological risk. Esvelt has consistently argued that because some biotechnologies can affect entire communities or ecosystems, people potentially impacted should be involved in decisions from the outset.

Why transparency matters

Traditional scientific culture often rewards secrecy until a result is ready for publication. Esvelt’s work on CRISPR gene drives pushed back against that norm; his group described the potential and risks of the technology publicly before building it in the lab, inviting broader scrutiny and debate.

Applied to pandemic risk, a more transparent approach might include:

• Openly sharing high-level risk assessments for new research directions
• Consulting with ethicists, policymakers, and communities before deploying ecological or public health interventions
• Publishing defensive tools — such as screening algorithms and surveillance architectures — so they can be globally adopted and improved

Trust is also crucial for effective response. Population-wide testing, vaccination campaigns, and behavioral measures depend on public confidence that authorities are acting in the public interest and basing decisions on sound evidence.[11][13]

What Individuals and Institutions Can Do Now

Preventing catastrophic pandemics is a collective task, but there are concrete steps that different actors can take today.

For governments and international bodies

• Mandate or strongly incentivize DNA synthesis screening for domestic providers.
• Invest in national wastewater and air surveillance networks, aligned with international standards.[12]
• Support research on broad-spectrum vaccines, antivirals, and far-UVC as part of national security planning.[14]
• Update biosafety and dual-use oversight frameworks in consultation with scientific and security experts.[13]

For the scientific community

• Adopt responsible publication and communication norms that recognize dual-use risks.
• Participate in the design and governance of screening and surveillance systems.
• Engage with local communities when research could affect their environment or health.

For concerned citizens and institutions

• Support policies that invest in early-warning infrastructure, not just crisis response.
• Advocate for improved indoor air quality standards in schools, workplaces, and public spaces.[11]
• Encourage educational programs that foster understanding of both the benefits and risks of modern biotechnology.

Frequently Asked Questions

Q: Are catastrophic engineered pandemics really plausible, or mostly science fiction?

A: The majority of emerging infectious diseases are still natural. However, expert assessments, including those informing national security strategies, treat engineered pandemics as a serious and growing risk because the tools needed to design and modify pathogens are becoming more powerful and accessible. The point of Esvelt’s proposals is to build systems that make such scenarios far less likely to occur or succeed.

Q: Would stronger biosafety rules and DNA screening stop beneficial research?

A: Properly designed safeguards aim to reduce access to biologically dangerous capabilities while leaving routine research largely unaffected. DNA synthesis screening, for example, can be automated and integrated into existing commercial workflows, adding minimal friction for legitimate users but blocking obviously hazardous sequence orders. Policymakers and scientists continue to refine these systems to balance security with scientific progress.

Q: How realistic is a global nucleic acid observatory?

A: Many of the core components already exist. Wastewater surveillance for SARS-CoV-2 has been deployed by several countries and demonstrated its ability to detect viral trends before clinical data does.[12] Scaling this into a global, multi-pathogen system would require major investment, coordination, and standardization, but it builds on proven scientific and engineering techniques.

Q: What role did gene drives play in changing how Esvelt thinks about risk?

A: Recognizing that CRISPR gene drives could, in principle, alter wild populations of entire species led Esvelt to advocate for unusually open and cautious research practices. That experience of confronting an unexpectedly powerful technology shaped his later emphasis on transparency, community engagement, and building defensive infrastructure before crises emerge.

Q: How does this agenda relate to preventing the next COVID-19?

A: Many measures described here — environmental surveillance, rapid vaccine platforms, improved ventilation, and better biosafety governance — would strengthen defenses against both engineered and natural pandemics.[11][12][14] Investing in them is not only about low-probability extreme scenarios; it also improves routine public health and resilience to the more likely outbreaks we know will continue to occur.

Written by

Medha Deb

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts. Medha specializes in the areas of beauty, health, sports, and wellness and is committed to ensuring that the content on the website is…